Hudson Bay Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,284	Closed	-$1.04M	–	883
2023 Q2	$1.04M	Buy	+13,284	New	+$1.04M	0.01%	517